Sarah Cavanaugh

Companies

• Celldex TherapeuticsSVP of Corp Affairs & Admin. Jun 16, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Celldex Therapeutics CLDX1,860 shares²$55.0K at $29.55May 30, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• May 30, 2024Sold 20,853 shares at $33.73 of Celldex Therapeutics²
• May 30, 2024Exercised options 10,103 shares at $9.02 of Celldex Therapeutics²
• May 30, 2024Exercised options 10,750 shares at $2.78 of Celldex Therapeutics²
• Aug 18, 2022Sold 1,355 shares at $36.38 of Celldex Therapeutics³
• Aug 18, 2022Exercised options 1,355 shares at $9.02 of Celldex Therapeutics³
• Aug 17, 2022Sold 31,312 shares at $36.73 of Celldex Therapeutics³
• Aug 17, 2022Exercised options 31,312 shares at $2.78 of Celldex Therapeutics³
• Dec 8, 2021Sold 7,323 shares at $40.00 of Celldex Therapeutics⁴
• Dec 8, 2021Exercised options 5,466 shares at $10.38 of Celldex Therapeutics⁴
• Dec 8, 2021Exercised options 1,857 shares at $9.02 of Celldex Therapeutics⁴
• Nov 1, 2021Sold 2,120 shares at $41.62 of Celldex Therapeutics⁵
• Nov 1, 2021Sold 901 shares at $43.06 of Celldex Therapeutics⁵
• Nov 1, 2021Sold 4,302 shares at $44.11 of Celldex Therapeutics⁵
• Nov 1, 2021Exercised options 938 shares at $2.78 of Celldex Therapeutics⁵
• Nov 1, 2021Exercised options 5,018 shares at $9.02 of Celldex Therapeutics⁵